President Joe Biden has announced his intention to appoint Dr. W. Kimryn Rathmell as the Director of the National Cancer Institute (NCI). The NCI is the federal government's leading agency for cancer research and training and the largest funder of cancer research globally. Dr. Rathmell is a respected physician-scientist and cancer expert with international recognition. She is well-suited to lead the NCI and achieve the goals set by President Biden for the Biden Cancer Moonshot. Dr. Rathmell's career has focused on advancing scientific research, patient care, and training the next generation of researchers. Her appointment reflects the commitment to improving outcomes and support for those facing cancer. Dr. Rathmell's research primarily focuses on kidney cancer and understanding its underlying drivers through genetic and molecular approaches. She has held various national leadership roles, including with the National Institute of Health's Cancer Genome Atlas and the Department of Defense Kidney Cancer Research Program. Dr. Rathmell's dedication and contributions have earned her national recognition, and she has received prestigious awards for her work in cancer research. She has also founded a non-profit organization to support patients with a rare cancer primarily affecting African-American individuals with sickle cell trait. Dr. Rathmell's educational background includes degrees in biology and chemistry from the University of Northern Iowa, a Ph.D. in Biophysics and an M.D. from Stanford University. She has completed her post-doctoral training at the University of North Carolina at Chapel Hill and holds a Masters of Management in Healthcare from Vanderbilt University's Owen Graduate School of Management.